❌

Reading view

A meta-analysis on global change drivers and the risk of infectious disease

Nature, Published online: 08 May 2024; doi:10.1038/s41586-024-07380-6

Reducing greenhouse gas emissions, managing ecosystem health, and preventing biological invasions and biodiversity loss could help to reduce the burden of plant, animal and human diseases, especially when coupled with improvements to social and economic determinants of health.
  •  

Pan-cancer proteogenomics characterization of tumor immunity

Immunotherapy holds strong promise for cancer treatment but at present benefits only a small proportion of cases. A pan-cancer analysis of the immune landscape in more than 1,000 tumors across ten cancer types reveals immune surveillance and immune evasion mechanisms as well as potential molecular target that could augment future immunotherapy and precision medicine strategies.
  •  
  •  

The extracellular matrix dictates regional competence for tumour initiation

Nature, Published online: 15 November 2023; doi:10.1038/s41586-023-06740-y

Experiments in mice show that expression of the oncogene SmoM2 induces basal cell carcinoma in the ear epidermis but not in the back skin, and that this difference in susceptibility is regulated by the extracellular matrix.
  •  

Large language models encode clinical knowledge

Nature, Published online: 12 July 2023; doi:10.1038/s41586-023-06291-2

Med-PaLM, a state-of-the-art large language model for medicine, is introduced and evaluated across several medical question answering tasks, demonstrating the promise of these models in this domain.
  •  

Single-cell spatial landscapes of the lung tumour immune microenvironment

Nature, Published online: 01 February 2023; doi:10.1038/s41586-022-05672-3

Using imaging mass cytometry, the tumour and immunological spatial landscapes of 416 lung adenocarcinomas are characterized, which, when combined with deep learning, can predict clinical outcomes with high accuracy.
  •  

Spatial genomics maps the structure, nature and evolution of cancer clones

Nature, Published online: 09 November 2022; doi:10.1038/s41586-022-05425-2

A workflow centred around base-specific in situ sequencing generates detailed maps of, and can phenotypically characterize, the unique set of subclones of cancers.
  •  

Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome

Nature, Published online: 05 October 2022; doi:10.1038/s41586-022-05169-z

Cleaved and intact type I collagen have different effects on pancreatic ductal adenocarcinoma (PDAC), and remodelling of type I collagen—mediated through DDR1 signalling—is a prognostic indicator for the survival of patients with PDAC.
  •  
❌